Atlanta
Amgen to buy Horizon Therapeutics for $28 billion cash
[ad_1]
Amgen, which has R&D operations in South San Francisco and has been an opportunistic buyer of Bay Area drug developers, has emerged as the winner of a competition to buy Horizon.
[ad_2]
[ad_2]
Share this news on your Fb,Twitter and Whatsapp
Times News Network:Latest News Headlines
Times News Network||Health||New York||USA News||Technology||World News